Ruzieh, Mohammed
Mandrola, John
Dyer, Anne-Marie
Chinchilli, Vernon M.
Naccarelli, Gerald V.
Foy, Andrew J.
Article History
Accepted: 29 August 2020
First Online: 16 September 2020
Declarations
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: AJF, MR, JM, A-MD, and VMC have no conflicts of interest that are directly relevant to the content of this article. GVN has served as a consultant/advisory board member for Janssen, GlaxoSmithKline, and Omeicos and received research support from Janssen.
: This study was approved by the institutional review board at Penn State College of Medicine, PA, USA, who determined that all criteria for exemption were met.
: This study used deidentified data from the AFFIRM trial study participants, and therefore a consent was not required.
: Not applicable.
: This study data were obtained from the NHLBI BioLINCC which prevents the redistribution of data. Raw data can be requested directly from the NHLBI BioLINCC ().
: The data are available via NIH BioLINCC for free.
: AJF: study desgin. AJF, MR, GVN, JM, AMD, VMC: manuscript writing, critical revisions. AMD, VMC: statistical analysis.